Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7

Abstract

The metabolism of tumor cells (tumor metabolome) is characterized by a high concentration of glycolytic enzymes including pyruvate kinase isoenzyme type M2 (M2-PK), a high glutaminolytic capacity, high fructose 1,6-bisphosphate (FBP) levels and a low (ATP+GTP):(CTP+UTP) ratio. The sequence of events required for the establishment of the tumor metabolome is presently unknown. In non-transformed rat kidney (NRK) cells we observed a high glutaminolytic flux rate and a low (ATP+GTP):(CTP+UTP) ratio, whereas FBP levels and M2-PK activity are still extremely low. After stable expression of oncogenic ras in NRK cells a strong upregulation of FBP levels and of M2-PK activity was observed. Elevated FBP levels induce a tetramerization of M2-PK and its migration into the glycolytic enzyme complex. AMP levels increase whereas UTP and CTP levels strongly decrease. Thus, ras expression completes the glycolytic part of tumor metabolism leading to the inhibition of nucleic acid synthesis and cell proliferation. The HPV-16 E7 oncoprotein, which cooperates with ras in cell transformation, directly binds to M2-PK, induces its dimerization and restores nucleic acid synthesis as well as cell proliferation. Apparently, the combination of the different metabolic effects of ras and E7 constructs the perfect tumor metabolome as generally found in tumor cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aon MA, Monaco ME, Cortassa S . 1995 Exp. Cell Res. 217: 42–51

  • Bedell MA, Jones KH, Laimins LA . 1987 J. Virol. 61: 3635–3640

  • Board M, Humm S, Newsholme EA . 1990 Biochem. J. 265: 503–509

  • Boros LG, Puigjaner J, Cascante M, Lee W-N, Brandes JL, Bassilian S, Yusuf FI, Williams RD, Muscarella P, Melvin WS, Schirmer WJ . 1997 Cancer Res. 57: 4242–4248

  • Boros LG, Torday JS, Lim S, Bassilian S, Cascante M, Lee W-NP . 2000 Cancer Res. 60: 1183–1185

  • Brazill DT, Thorner J, Martin GS . 1997 J. Bacteriol. 179: 4415–4418

  • Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E . 1998 Nature 394: 485–490

  • Cascante M, Centelles JJ, Veech RL, Lee W-NP, Boros LG . 2000 Nutr. Cancer 36: 150–154

  • Chopade BA, Shankar S, Sundin GW, Mukhopadhyay S, Chakrabarty AM . 1997 J. Bacteriol. 179: 2181–2188

  • Crook T, Morgenstern JP, Crawford L, Banks L . 1989 EMBO J. 8: 513–519

  • Dang CV, Semenza GL . 1999 TIBS 24: 68–72

  • Downes CS, Bachrati CZ, Devlin SJ, Tommasino M, Cutts TJR, Watson JV, Rasko I, Johnson RT . 2000 J. Cell Sci. 113: 1089–1096

  • Dupriez VJ, Darville MI, Antoine IV, Gegonne A, Ghysdael J, Rousseau GG . 1993 Proc. Natl. Acad. Sci. USA 90: 8224–8228

  • Eigenbrodt E, Fister P, Reinacher M . 1985 Regulation of Carbohydrate Metabolism. Beitner R. (ed.) CRC Press Inc.: Boca Raton, Fl pp. 141–179

    Google Scholar 

  • Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P . 1998a Anticancer Res. 18: 3267–3274

  • Eigenbrodt E, Mazurek S, Friis RR . 1998b Cell Growth and Oncogenesis. Bannasch P, Kanduc D, Papa S and Tager JM. (eds). Birkhäuser Verlag: Basel pp. 15–30

    Book  Google Scholar 

  • Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R . 1992 Crit. Rev. Oncol. 3: 91–115

  • Glass-Marmor L, Beitner R . 1999 Eur. J. Pharmacol. 370: 195–199

  • Glossmann H, Presek P, Eigenbrodt E . 1981 Mol. Cell. Endocrinol. 23: 49–63

  • Gregory SH, Kumari HL, Lakshimi MV, Bose SK . 1976 Arch. Biochem. Biophys. 175: 644–653

  • Henderson JF, Scott FW . 1981 Pharma. Ther. 8: 539–571

  • Hunting D, Hordern J, Henderson JF . 1981 Can. J. Biochem. 59: 821–829

  • Inouye S, Yamada Y, Miura K, Suzuki H, Kawata K, Shinoda K, Nakazawa A . 1999 Biochem. Biophys. Res. Commun. 254: 618–622

  • Jackson RC, Lui MS, Boritzki TJ, Morris HP, Weber G . 1980 Cancer Res. 40: 1286–1291

  • Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, DiPaolo JA, Peehl DM, Giaccia AJ . 1997 Cancer Res. 57: 4200–4204

  • Kohler C, Gahm A, Noma T, Nakazawa A, Orrenius S, Zhivotovsky B . 1999 FEBS Lett. 447: 10–12

  • Kole HK, Resnick RJ, van Doren M, Racker E . 1991 Arch. Biochem. Biophys. 286: 586–590

  • Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM . 1996 Genes. Dev. 10: 934–947

  • Mazurek S, Boschek CB, Eigenbrodt E . 1997a J. Bioenerg. Biomemb. 29: 315–330

  • Mazurek S, Eigenbrodt E, Failing K, Steinberg P . 1999 J. Cell. Physiol. 181: 136–146

  • Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E . 2001a Br. J. Nutr In press

  • Mazurek S, Grimm H, Wilker S, Leib S, Eigenbrodt E . 1998 Anticancer Res. 18: 3275–3282

  • Mazurek S, Hugo F, Failing K, Eigenbrodt E . 1996 J. Cell. Physiol. 167: 238–250

  • Mazurek S, Michel A, Eigenbrodt E . 1997b J. Biol. Chem. 272: 4941–4952

  • Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E . 2001b Biochem. J. 356: 247–256

  • Moyer JD, Smith PA, Levy EJ, Handschumacher RE . 1982 Cancer Res. 42: 4525–4531

  • Nagy E, Henics T, Eckert M, Miseta A, Lightowlers RN, Kellermayer M . 2000 Biochem. Biophys. Res. Commun. 275: 253–260

  • Nagy E, Rigby FC . 1995 J. Biol. Chem. 270: 2755–2763

  • Noma T, Adachi N, Nakazawa A . 1999 Biochem. Biophys. Res. Commun. 264: 990–997

  • Penso J, Beitner R . 1998 Eur. J. Pharmacol. 342: 113–117

  • Presek P, Reinacher M, Eigenbrodt E . 1988 FEBS Lett. 242: 194–198

  • Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, Alunni-Fabbroni M, Casavola V, Tommasino M . 2000 FASEB J. 14: 2185–2197

  • Ryll T, Wagner R . 1992 Biotechnol. Bioeng. 40: 934–946

  • Schäfer D, Hamm-Künzelmann B, Brand K . 1997 FEBS Lett. 417: 325–328

  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602

  • Shim H, Chun YS, Lewis BC, Dang CV . 1998 Proc. Natl. Acad. Sci. USA 95: 1511–1516

  • Shim H, Dolde C, Lewis BC, Wu C-S, Dang G, Jungmann RA, Dalla-Favera R, Dang CV . 1997 Proc. Natl. Acad. Sci. USA 94: 6658–6663

  • Thomas S, Fell DA . 1998 Eur. J. Biochem. 258: 956–967

  • Weber G, Stubbs M, Morris HP . 1971 Cancer Res. 31: 2177–2183

  • Zwerschke W, Jansen-Dürr P . 2000 Adv. Cancer Res. 78: 1–29

  • Zwerschke W, Mazurek S, Massimi P, Banks, Eigenbrodt E, Jansen-Dürr P . 1999 Proc. Natl. Acad. Sci. USA 96: 1291–1296

Download references

Acknowledgements

This work was supported by the Land Hessen (S Mazurek: HSP III), the Deutsche Forschungsgemeinschaft (S Mazurek: Ma 1760 1-2 and 2-1) and in P Jansen-Dürr's laboratory by the Austrian Science Funds (FWF), the European Union (Biomed 2) and the Austrian Ministry of Science and Traffic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sybille Mazurek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazurek, S., Zwerschke, W., Jansen-Dürr, P. et al. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene 20, 6891–6898 (2001). https://doi.org/10.1038/sj.onc.1204792

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204792

Keywords

This article is cited by

Search

Quick links